Next Data Submission for Remdesivir Distribution
Yesterday, the Department of Health and Human Services (HHS) announced the next deadline to submit data to inform remdesivir distribution is Monday (May 18) at 11:59 p.m. ET. HHS requests hospitals submit at least six admission and intensive care unit data fields into the HHS Protect System – TeleTracking portal on a weekly basis; the first deadline was earlier this week on May 12. Hospitals that already use the TeleTracking portal for daily capacity and utilization data submission do not need to do anything differently.
If your hospital has not received access to the TeleTracking portal or for questions regarding data submission, please contact TeleTracking Technical Support at (877) 570-6903. For information on daily capacity and utilization data submission, please see the GNYHA bulletin.
Updates on Remdesivir Distribution
The HHS Office of the Assistant Secretary of Preparedness and Response (ASPR) held an open call with stakeholder organizations on May 14. On the call, ASPR shared that approximately 40% of total donated doses for domestic purposes will have been distributed to states and a small amount sent to Indian Health Services and the Veterans Administration. The remaining will be sent to states over a six-week period, with state departments of health allocating received drugs to hospitals. HHS anticipates that no additional remdesivir will be available until sometime after the end of August, at the earliest. Per the HHS Task Force on Healthcare Resiliency, hospitals that have received donated remdesivir through the Emergency Use Authorization process may share doses within their own health systems or among other health systems if appropriate record-keeping requirements are met. The US Food and Drug Administration sent Gilead, the drug company that donated remdesivir, an Emergency Use Authorization letter on May 1 that outlines inventory control requirements for hospitals dispensing remdesivir.